Tradestie Institutional Equity Comparison Engine

CYTK vs VNDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VNDA Overall Edge

VNDA Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vanda Pharmaceuticals Inc. (VNDA) driven by superior Valuation, Growth & Margin, Momentum & Technical while CYTK counters with relative strength in Options & Structure. Fundamentally, CYTK trades at 117.7x Forward P/E with -625.2% operating margin (+2356.5% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, CYTK sits in BREAKDOWN (28th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VNDA
CYTK 117.7x vs VNDA 103.1x Fwd P/E
Growth & Margin Winner VNDA
Op Margin -625.2% vs -77.6% ยท YoY +2356.5% vs +24.1%
Momentum & Technical Winner VNDA
1Y -18.8% vs -12.6% ยท 52W Pos 1% vs 4%
Options & Structure Winner CYTK
BREAKDOWN (28th %ile IV) vs BREAKDOWN (75th %ile IV)
CYTK NASDAQ
Cytokinetics Inc.
Pharmaceutical Preparations
$53.18
-5.26% 1D
Market Cap $7.8B
1M Return -14.16%
1Y Return -18.83%
Forward P/E 117.7x
Unified AI Score
57.6 / 100 HOLD
Tech 33.0 Fund 57.0 Flow 72.0 Mom 60.0
VNDA NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap $238.9M
1M Return -5.83%
1Y Return -12.56%
Forward P/E 103.1x
Unified AI Score
49.0 / 100 HOLD
Tech 56.0 Fund 58.0 Flow 65.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CYTK -18.83% VNDA -12.56% Spread: +6.27 pp (VNDA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CYTK Revenue VNDA Revenue CYTK Op. Margin VNDA Op. Margin Margin Edge
FY2018 $30M $190M -282.3% 11.3% VNDA
FY2019 $30M $230M -368.0% 10.0% VNDA
FY2020 $60M $250M -168.3% 11.0% VNDA
FY2021 $70M $270M -264.5% 15.7% VNDA
FY2022 $90M $250M -342.8% 2.5% VNDA
FY2023 $10M $190M -6589.7% -7.2% VNDA
FY2024 $20M $200M -2902.7% -20.5% VNDA
FY2025 $90M $220M -695.4% -70.0% VNDA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CYTK (5) vs VNDA (5)
Institutional Metric CYTK VNDA Criterion Row Winner
Market Capitalization Scale $7.8B $238.9M Larger Scale CYTK
Trailing P/E Ratio Valuation 117.7x 103.1x Lower Multiple VNDA
Forward P/E Ratio Valuation 117.7x 103.1x Lower Multiple VNDA
Revenue Growth (YoY) Growth +2356.5% +24.1% Higher Growth CYTK
Operating Margin (TTM) Profitability -625.2% -77.6% Higher Margin VNDA
Net Profit Margin Profitability 0.0% -119.9% Higher Margin CYTK
Return on Equity (ROE) Capital Efficiency -572.1% -82.5% Higher ROE VNDA
52-Week Range Position Momentum 1% ($53โ€“$88) 4% ($4โ€“$10) Stronger Trend VNDA
Beta / 30D Volatility Risk Regime 1.09ฮฒ ยท 58% Vol 1.25ฮฒ ยท 61% Vol Lower Realized Risk CYTK
Unified Institutional Score Composite Signal 57.6 / 100 (HOLD) 49.0 / 100 (HOLD) Higher Composite CYTK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CYTK vs VNDA Buy Guide
CYTK BREAKDOWN
98d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CYTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VNDA BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 75th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VNDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CYTK nor VNDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.